HKSE - Delayed Quote HKD

Laekna, Inc. (2105.HK)

Compare
10.840 -1.040 (-8.75%)
At close: 4:08:20 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
305,893.000
305,893.000
393,314.000
225,029.000
Operating Income
-305,893.000
-305,893.000
-393,314.000
-225,029.000
Net Non Operating Interest Income Expense
12,261.000
12,261.000
-566.000
-513.000
Pretax Income
-368,814.000
-368,814.000
-781,594.000
-748,964.000
Net Income Common Stockholders
-368,814.000
-368,814.000
-781,594.000
-748,964.000
Diluted NI Available to Com Stockholders
-368,814.000
-368,814.000
-781,594.000
-748,964.000
Basic EPS
-1.68
--
-20.04
-1.92
Diluted EPS
-1.68
--
-20.04
-1.92
Basic Average Shares
219,592.000
--
39,010.035
390,100.350
Diluted Average Shares
219,592.000
--
390,100.350
390,100.350
Total Operating Income as Reported
-295,877.000
-295,877.000
-393,149.000
-225,610.000
Rent Expense Supplemental
--
--
1,844.000
868.000
Total Expenses
305,893.000
305,893.000
393,314.000
225,029.000
Net Income from Continuing & Discontinued Operation
-368,814.000
-368,814.000
-781,594.000
-748,964.000
Normalized Income
-299,888.000
-299,888.000
-398,233.000
-226,532.000
Interest Income
13,988.000
13,988.000
823.000
409.000
Interest Expense
1,727.000
1,727.000
1,389.000
922.000
Net Interest Income
12,261.000
12,261.000
-566.000
-513.000
EBIT
-367,087.000
-367,087.000
-780,205.000
-748,042.000
EBITDA
-361,754.000
-361,754.000
-773,538.000
-742,216.000
Reconciled Depreciation
5,333.000
5,333.000
6,667.000
5,826.000
Net Income from Continuing Operation Net Minority Interest
-368,814.000
-368,814.000
-781,594.000
-748,964.000
Total Unusual Items Excluding Goodwill
-68,926.000
-68,926.000
-383,361.000
-522,432.000
Total Unusual Items
-68,926.000
-68,926.000
-383,361.000
-522,432.000
Normalized EBITDA
-292,828.000
-292,828.000
-390,177.000
-219,784.000
12/31/2021 - 6/29/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1541.HK IMMUNEONCO-B
6.140
+1.99%
 
300149.SZ ChemPartner PharmaTech Co.,Ltd.
8.01
+4.43%
 
078160.KQ MEDIPOST Co., Ltd.
15,030.00
+5.99%
 
0ITA.BE Satellos Bioscience Inc
0.6700
+4.69%
 
2487.HK Cutia Therapeutics
7.010
-1.27%
 
2511.HK HighTide Therapeutics, Inc.
0.960
0.00%
 
2162.HK Keymed Biosciences Inc.
34.550
-8.84%
 
6628.HK Transcenta Holding Limited
0.610
0.00%
 
9969.HK InnoCare Pharma Limited
6.150
-0.32%
 
1477.HK OCUMENSION-B
4.710
-2.48%